Akari Therapeutics Plc (AKTX)
7.52
-0.33
(-4.20%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Shareholders Equity (Quarterly) : 18.60M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.60M |
| March 31, 2026 | 14.38M |
| December 31, 2025 | 28.33M |
| September 30, 2025 | 22.69M |
| June 30, 2025 | 25.60M |
| March 31, 2025 | 21.75M |
| December 31, 2024 | 22.23M |
| September 30, 2024 | -6.694M |
| June 30, 2024 | -3.703M |
| March 31, 2024 | -3.553M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 8.326M |
| March 31, 2022 | 13.93M |
| December 31, 2021 | 5.555M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 1.588M |
| March 31, 2021 | 3.937M |
| December 31, 2020 | 9.384M |
| September 30, 2020 | 4.858M |
| June 30, 2020 | 3.339M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.816M |
| December 31, 2019 | -1.772M |
| September 30, 2019 | 3.250M |
| June 30, 2019 | -1.372M |
| March 31, 2019 | 1.220M |
| December 31, 2018 | 3.111M |
| September 30, 2018 | 6.303M |
| June 30, 2018 | 8.627M |
| March 31, 2018 | 16.32M |
| December 31, 2017 | 17.15M |
| September 30, 2017 | 13.04M |
| June 30, 2017 | 22.85M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 34.46M |
| September 30, 2016 | 41.04M |
| June 30, 2016 | 40.58M |
| March 31, 2016 | 46.36M |
| December 31, 2015 | 48.72M |
| September 30, 2015 | 41.33M |
| June 30, 2015 | 0.973M |
| March 31, 2015 | 2.595M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 41.07M |
| argenx SE | -- |
| Autolus Therapeutics Plc | 74.84M |
| Evaxion AS | 9.531M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.62M |
| Total Liabilities (Quarterly) | 20.03M |
| Debt to Equity Ratio | 0.0373 |
| Current Ratio | 0.5973 |
| Net Debt Paydown Yield | 1.29% |